Could a lactic acid shot ease your back pain?
NCT ID NCT04673461
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested an injection called STA363, made from lactic acid, for people with long-term low back pain from damaged spinal discs. About 110 adults who had not gotten relief from other treatments received either a low dose, a high dose, or a placebo injection into their painful discs. The main goal was to see if the treatment reduced pain over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lactic acid (STA363)
What this could lead to
If it works, this could offer a new injection-based treatment for chronic low back pain caused by damaged discs, potentially reducing pain without surgery.
What could go wrong
This is an early Phase 2 trial with only 110 people, so results may not apply to everyone. The treatment is still experimental, and its long-term safety and effectiveness are not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISCOGENIC PAIN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alrijne Ziekenhuis Leiderdorp
Leiderdorp, Netherlands
-
Bekhterev Psychiatry and Neurology Center
Saint Petersburg, Russia
-
Belgorod Regional Clinical Hospital of Saint Joasaph
Belgorod, Russia
-
Complejo Hospitalario Ruber Juan Bravo
Madrid, Spain
-
Hm Puerta Del Sur
Móstoles, Spain
-
Hospital Quirónsalud Córdoba
Córdoba, Spain
-
Hospital Universitario Quirónsalud Madrid
Pozuelo de Alarcón, Spain
-
Kirov State Medical University
Kirov, Russia
-
Krasnoyarsk Interdistrict Clinical Emergency Hospital
Krasnoyarsk, Russia
-
LLC MART
Saint Petersburg, Russia
-
Ochapovsky Regional Clinical Hospital #1
Krasnodar, Russia
-
Privolzhsky Research Medical University
Nizhny Novgorod, Russia
-
Regional Clinical Hospital #3
Chelyabinsk, Russia
-
Rijnstate Hospital Anesthesiology and Pain
Velp, Netherlands
-
Siberian Research Clinical Center
Krasnoyarsk, Russia
-
Smolensk Regional Clinical Hospital
Smolensk, Russia
-
Tula Regional Clinical Hospital
Tula, Russia